EAGLE ASSET MANAGEMENT INC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 263 filers reported holding CONMED CORP in Q4 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$20,067,334
+24.2%
198,982
+67.3%
0.12%
+32.2%
Q2 2023$16,163,571
+41.2%
118,946
+7.9%
0.09%
+34.3%
Q1 2023$11,451,000
+19.9%
110,260
+3.6%
0.07%
+13.6%
Q4 2022$9,549,000
+31.2%
106,396
+17.2%
0.06%
+22.9%
Q3 2022$7,280,000
-83.0%
90,808
-79.7%
0.05%
-82.1%
Q2 2022$42,742,000
-43.8%
446,355
-12.8%
0.27%
-31.1%
Q1 2022$76,042,000
+2.8%
511,898
-0.8%
0.39%
+20.1%
Q4 2021$73,985,000
+6.0%
516,225
-3.2%
0.32%
+2.9%
Q3 2021$69,784,000
-9.4%
533,401
-4.9%
0.32%
-4.8%
Q2 2021$77,051,000
-11.4%
560,657
-16.5%
0.33%
-14.0%
Q1 2021$86,960,000
+19.6%
671,353
+3.4%
0.38%
-6.1%
Q4 2020$72,727,000
+107.4%
649,350
+42.8%
0.41%
+126.5%
Q3 2020$35,068,000
+10.5%
454,728
-0.5%
0.18%
+0.6%
Q2 2020$31,728,000
+25.9%
457,116
+3.9%
0.18%
+14.6%
Q1 2020$25,196,000
-44.8%
439,959
+7.7%
0.16%
-28.3%
Q4 2019$45,681,000
+32.6%
408,495
+14.0%
0.22%
+23.0%
Q3 2019$34,443,000
+231.2%
358,231
+194.7%
0.18%
+235.8%
Q2 2019$10,401,000
+34.8%
121,551
+31.1%
0.05%
+29.3%
Q1 2019$7,715,000
-43.5%
92,751
-70.0%
0.04%
-44.6%
Q2 2014$13,643,000
-1.6%
309,020
-3.1%
0.07%
-2.6%
Q1 2014$13,858,000318,9640.08%
Other shareholders
CONMED CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Endurant Capital Management LP 41,984$4,234,0863.80%
Ranger Investment Management 334,874$33,772,0432.24%
SECTORAL ASSET MANAGEMENT INC 114,000$11,496,9002.24%
EARNEST PARTNERS LLC 2,265,092$228,434,5281.32%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 144,376$14,560,3201.01%
EPIQ PARTNERS, LLC 10,463$1,055,1940.80%
Hood River Capital Management LLC 236,127$23,813,4080.76%
Heritage Wealth Partners, LLC 3,375$340,3690.73%
Champlain Investment Partners, LLC 943,260$95,127,7710.62%
WESTWOOD HOLDINGS GROUP INC 559,157$56,3910.53%
View complete list of CONMED CORP shareholders